Directory
>
Hans Van Bruggen
Hans Van Bruggen
Chief Scientific Officer | Astellas Pharma Singapore
North Brabant, Netherlands
Hans Van Bruggen
Summary
Hans Van Bruggen is a seasoned Chief Scientific Officer at Celegence, specializing in regulatory information management within the pharmaceutical industry. With a robust background in biopharmaceuticals and regulatory affairs, he has a proven track record of ensuring high-quality drug development through meticulous regulatory submissions and compliance. Hans's expertise extends across various facets of clinical development, including clinical trials and pharmacovigilance, making him a key player in the lifecycle of drug products. His visionary approach emphasizes the importance of integrating scientific content with regulatory requirements, ultimately benefiting patient populations. He is also actively involved in professional organizations, contributing to the advancement of regulatory practices. Fluent in English, Hans has a strong educational foundation with an MSc in Pharmaceutical Medicine from the University of Surrey, further enhancing his credibility in the field.
Hans Van Bruggen
Work Experience
Chief Scientific Officer at
Celegence
July 2022 - Present
Regulatory Operations service provider at
Dätwyler Holding AG
December 2015 - Present
Regulatory Operations service provider at
CRYOQUIP PTY LTD
September 2015 - Present
Regulatory Operations service provider at
Leadiant Biosciences Ltd
October 2014 - Present
XEVMPD and IDMP service provider and Regulatory Affairs consultant at
B. Braun Group
January 2012 - Present
Regulatory Operations service provider at
Astellas Pharma Singapore
January 2007 - Present
Presenter and Co-organiser at
TOPRA - The Organisation for Professionals in Regulatory Affairs
January 2006 - Present
Presenter and Co-organiser at
D I A JAPAN, GENERAL INC. ASSOCIATION
January 2001 - Present
Regulatory Operations service provider and Regulatory Affairs consultant at
Santen Pharmaceutical
January 2014 - April 2024
Board Member at
IRISS Forum (IRISS-Forum.org)
August 2016 - April 2024
Regulatory Operations service provider at
Intercept Pharmaceuticals
January 2014 - April 2024
Owner and Senior Regulatory Affairs Scientist at
Qdossier
January 2006 - July 2022
Regulatory Affairs consultant at
Acolad Switzerland AG
October 2013 - July 2022
Regulatory Operations service provider at
PRODOTTI CHIMICI E ALIMENTARI S.P.A.
August 2016 - December 2016
Regulatory Operations service provider at
Genzyme Europe B.V.
January 2012 - May 2016
Regulatory Affairs consultant at
GSK
January 2009 - February 2016
Regulatory Operations service provider and Regulatory Affairs consultant at
Prosensa Therapeutics
February 2014 - June 2015
Instructor at
UNI STRATEGIC (MALAYSIA) SDN. BHD.
January 2015 - January 2015
Presenter at
Regulatory Affairs Professionals Society (RAPS)
January 2009 - January 2014
Regulatory Operations service provider at
Catalent, Inc.
January 2013 - December 2013
Hans Van Bruggen
Education
University of Surrey, Msc
January 1999 - January 2003
OLAN, Comparable To Bsc
January 1979 - January 1983
Frequently Asked Questions about Hans Van Bruggen
What is Hans Van Bruggen email address?
Hans Van Bruggen's primary email address is ********@ectdconsultancy.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Hans Van Bruggen work for?
Hans Van Bruggen is a Chief Scientific Officer at Astellas Pharma Singapore, a company specializing in Biological products, except diagnostic.
Where Hans Van Bruggen graduated from?
Hans Van Bruggen holds a degree in Pharmaceutical Medicine from University of Surrey.
How can I directly contact Hans Van Bruggen?
To contact Hans Van Bruggen directly, you can use the email address ********@ectdconsultancy.com. Complete contact information is available upon registration with Muraena.
Who is Hans Van Bruggen?
Hans Van Bruggen is a seasoned Chief Scientific Officer at Celegence, specializing in regulatory information management within the pharmaceutical industry. With a robust background in biopharmaceuticals and regulatory affairs, he has a proven track record of ensuring high-quality drug development through meticulous regulatory submissions and compliance. Hans's expertise extends across various facets of clinical development, including clinical trials and pharmacovigilance, making him a key player in the lifecycle of drug products. His visionary approach emphasizes the importance of integrating scientific content with regulatory requirements, ultimately benefiting patient populations. He is also actively involved in professional organizations, contributing to the advancement of regulatory practices. Fluent in English, Hans has a strong educational foundation with an MSc in Pharmaceutical Medicine from the University of Surrey, further enhancing his credibility in the field.
Hans`s contact details
********@ectdconsultancy.com
***************@datwyler.com
********@qdossier.com
***************@santen.com
***************@astellas.com
***********@interceptpharma.com
***************@bbraun.com
***************@iriss-forum.org
Colleagues
Vp, Head Of Biometrics
Vice President RWE APAC
Executive Director, Discovery Bioscience, Gene Therapy Research & Tec Operations
Executive Director Global Marketing at Kite Pharma
VP Market Access - Acct Mgmt & Trade Relations
Senior Manager, US Commercial Communications